U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C14H18N2O
Molecular Weight 230.3055
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of PROPYPHENAZONE

SMILES

CC(C)C1=C(C)N(C)N(C1=O)C2=CC=CC=C2

InChI

InChIKey=PXWLVJLKJGVOKE-UHFFFAOYSA-N
InChI=1S/C14H18N2O/c1-10(2)13-11(3)15(4)16(14(13)17)12-8-6-5-7-9-12/h5-10H,1-4H3

HIDE SMILES / InChI

Description
Curator's Comment: description was created based on several sources, including https://www.medchemexpress.com/Propyphenazone.html?gclid=CKPT7oP5jM8CFUKeGwodv10NsQ

Propyphenazone is a pyrazolone derivative with anti-inflammatory, analgesic and antipyretic activity. The coupling of propyphenazone with other widely used acidic NSAIDs such as ketoprofen, ibuprofen, and diclofenac produced mutual prodrugs with synergistic analgesic effects. It was introduced for the treatment of different types of pain and fever and rheumatic disorders. Propyphenazone structurally relates to aminophenazone it has been associated with severe blood dyscrasias.

Originator

Curator's Comment: Hoffmann-La Roche had substituted an isopropyl group for the amino group of 4-amino-diethyl antipyrine. The resulting drug was propyphenazone http://www.druglead.com/cds/propyphenazone.html # 1934 to Hoffmann-La Roche

Approval Year

Targets

Targets

Primary TargetPharmacologyConditionPotency
Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Primary
saridon

Approved Use

It is indicated for: headache, toothache, nerve pain , lumbago, muscular pain, menstrual pain and fever and pain with influenza and viral rhinitis; fever and pain after vaccination

Launch Date

1983
Primary
saridon

Approved Use

It is indicated for: headache, toothache, nerve pain , lumbago, muscular pain, menstrual pain and fever and pain with influenza and viral rhinitis; fever and pain after vaccination

Launch Date

1983
Primary
saridon

Approved Use

It is indicated for: headache, toothache, nerve pain , lumbago, muscular pain, menstrual pain and fever and pain with influenza and viral rhinitis; fever and pain after vaccination

Launch Date

1983
Primary
saridon

Approved Use

It is indicated for: headache, toothache, nerve pain , lumbago, muscular pain, menstrual pain and fever and pain with influenza and viral rhinitis; fever and pain after vaccination

Launch Date

1983
Primary
saridon

Approved Use

It is indicated for: headache, toothache, nerve pain , lumbago, muscular pain, menstrual pain and fever and pain with influenza and viral rhinitis; fever and pain after vaccination

Launch Date

1983
PubMed

PubMed

TitleDatePubMed
Derivative ratio spectra-zero crossing spectrophotometry and LC method applied to the quantitative determination of paracetamol, propyphenazone and caffeine in ternary mixtures.
2001 Dec
Retrospective analysis of drug-induced urticaria and angioedema: a survey of 2287 patients.
2001 Nov
Drug-induced hepatitis with hepatic granuloma due to saridon.
2002
The onset of action and the analgesic efficacy of Saridon (a propyphenazone/paracetamol/ caffeine combination) in comparison with paracetamol, ibuprofen, aspirin and placebo (pooled statistical analysis).
2002
Drugs and personal care products as ubiquitous pollutants: occurrence and distribution of clofibric acid, caffeine and DEET in the North Sea.
2002 Aug 5
Advanced fibre optical scanning in thin-layer chromatography for drug identification.
2002 May 25
[Current aspects of the treatment of migraine].
2003 Jul-Aug
Wavelet analysis for the multicomponent determination in a binary mixture of caffeine and propyphenazone in tablets.
2004 Apr
Safety of the new selective cyclooxygenase type 2 inhibitors rofecoxib and celecoxib in patients with anaphylactoid reactions to nonsteroidal anti-inflammatory drugs.
2004 Oct
Detection and identification of phenazone-type drugs and their microbial metabolites in ground and drinking water applying solid-phase extraction and gas chromatography with mass spectrometric detection.
2004 Oct 1
Drug-induced anaphylaxis : case/non-case study based on an italian pharmacovigilance database.
2005
[Abuse pattern of analgesics in chronic daily headache: a study in the general population].
2005 Dec
Dipyrone and aminopyrine are effective scavengers of reactive nitrogen species.
2006
Mobility of pharmaceuticals carbamazepine, diclofenac, ibuprofen, and propyphenazone in miscible-displacement experiments.
2006 Feb 1
Inhibition of human neutrophil oxidative burst by pyrazolone derivatives.
2006 Feb 15
Celosomy is associated with prenatal exposure to cyclooxygenase inhibitors.
2006 Mar
Quantitative structure-pharmacokinetic relationships for drug clearance by using statistical learning methods.
2006 Mar
Pharmaceutical chemicals and endocrine disrupters in municipal wastewater in Tokyo and their removal during activated sludge treatment.
2006 Oct
Analysis of pharmaceuticals in wastewater and removal using a membrane bioreactor.
2007 Feb
Development of a multicommuted flow-through optosensor for the determination of a ternary pharmaceutical mixture.
2007 Jan 17
Determination of the analgesic components of Spasmomigraine tablet by liquid chromatography with ultraviolet detection.
2007 Jan-Feb
Development and validation of chemometrics-assisted spectrophotometry and liquid chromatography methods for the simultaneous determination of the active ingredients in two multicomponent mixtures containing chlorpheniramine maleate and phenylpropanolamine hydrochloride.
2007 Jul-Aug
Simultaneous determination of paracetamol, caffeine and propyphenazone in ternary mixtures by micellar electrokinetic capillary chromatography.
2007 Mar 1
Investigation of the behavior and metabolism of pharmaceutical residues during purification of contaminated ground water used for drinking water supply.
2007 Nov
Removal of selected pharmaceuticals and personal care products (PPCPs) and endocrine-disrupting chemicals (EDCs) during sand filtration and ozonation at a municipal sewage treatment plant.
2007 Nov
Removal of selected pharmaceuticals by chlorination, coagulation-sedimentation and powdered activated carbon treatment.
2008
Treatment of a landfill leachate containing compounds of pharmaceutical origin.
2008
Rejection of pharmaceuticals in nanofiltration and reverse osmosis membrane drinking water treatment.
2008 Aug
Determination of caffeine and associated compounds in food, beverages, natural products, pharmaceuticals, and cosmetics by micellar electrokinetic capillary chromatography.
2008 Feb
Comprehensive screening and quantification of veterinary drugs in milk using UPLC-ToF-MS.
2008 Jul
Evaluation of pharmaceuticals and personal care products as water-soluble molecular markers of sewage.
2008 Sep 1
Synaptopodin regulates plasticity of dendritic spines in hippocampal neurons.
2009 Jan 28
Quantification of 4-methylaminoantipyrine, the active metabolite of dipyrone, in human plasma.
2009 May
Acute myocardial infarction and Kounis syndrome.
2009 May 15
The characteristics of enriched nitrifier culture in the degradation of selected pharmaceutically active compounds.
2009 Nov 15
A case of linear immunoglobulin A bullous dermatosis in a patient exposed to sun and an analgesic.
2009 Sep
Patents

Sample Use Guides

single oral doses of 150 and 300 mg
Route of Administration: Oral
In Vitro Use Guide
Unknown
Name Type Language
PROPYPHENAZONE
EP   INN   MART.   MI   WHO-DD  
INN  
Official Name English
ISOPROPYLANTIPYRINE [JAN]
Common Name English
propyphenazone [INN]
Common Name English
ISOPROPYLANTIPYRINE
Common Name English
4-ISOPROPYL-2,3-DIMETHYL-1-PHENYL-3-PYRAZOLIN-5-ONE
Systematic Name English
PROPYPHENAZONE [MI]
Common Name English
Propyphenazone [WHO-DD]
Common Name English
ISOPROPYLPHENAZONE
Systematic Name English
PROPYPHENAZONE [EP MONOGRAPH]
Common Name English
PROPYPHENAZONE [MART.]
Common Name English
YOSHIPYRIN
Brand Name English
Classification Tree Code System Code
WHO-VATC QN02BB74
Created by admin on Fri Dec 15 15:19:50 GMT 2023 , Edited by admin on Fri Dec 15 15:19:50 GMT 2023
WHO-ATC N02BB74
Created by admin on Fri Dec 15 15:19:50 GMT 2023 , Edited by admin on Fri Dec 15 15:19:50 GMT 2023
WHO-VATC QN02BB04
Created by admin on Fri Dec 15 15:19:50 GMT 2023 , Edited by admin on Fri Dec 15 15:19:50 GMT 2023
WHO-VATC QN02BB54
Created by admin on Fri Dec 15 15:19:50 GMT 2023 , Edited by admin on Fri Dec 15 15:19:50 GMT 2023
NCI_THESAURUS C257
Created by admin on Fri Dec 15 15:19:50 GMT 2023 , Edited by admin on Fri Dec 15 15:19:50 GMT 2023
WHO-ATC N02BB04
Created by admin on Fri Dec 15 15:19:50 GMT 2023 , Edited by admin on Fri Dec 15 15:19:50 GMT 2023
WHO-ATC N02BB54
Created by admin on Fri Dec 15 15:19:50 GMT 2023 , Edited by admin on Fri Dec 15 15:19:50 GMT 2023
Code System Code Type Description
SMS_ID
100000092130
Created by admin on Fri Dec 15 15:19:50 GMT 2023 , Edited by admin on Fri Dec 15 15:19:50 GMT 2023
PRIMARY
ECHA (EC/EINECS)
207-539-2
Created by admin on Fri Dec 15 15:19:50 GMT 2023 , Edited by admin on Fri Dec 15 15:19:50 GMT 2023
PRIMARY
MERCK INDEX
m9252
Created by admin on Fri Dec 15 15:19:50 GMT 2023 , Edited by admin on Fri Dec 15 15:19:50 GMT 2023
PRIMARY Merck Index
DRUG CENTRAL
2309
Created by admin on Fri Dec 15 15:19:50 GMT 2023 , Edited by admin on Fri Dec 15 15:19:50 GMT 2023
PRIMARY
EVMPD
SUB10125MIG
Created by admin on Fri Dec 15 15:19:50 GMT 2023 , Edited by admin on Fri Dec 15 15:19:50 GMT 2023
PRIMARY
FDA UNII
OED8FV75PY
Created by admin on Fri Dec 15 15:19:50 GMT 2023 , Edited by admin on Fri Dec 15 15:19:50 GMT 2023
PRIMARY
INN
2848
Created by admin on Fri Dec 15 15:19:50 GMT 2023 , Edited by admin on Fri Dec 15 15:19:50 GMT 2023
PRIMARY
RXCUI
34710
Created by admin on Fri Dec 15 15:19:50 GMT 2023 , Edited by admin on Fri Dec 15 15:19:50 GMT 2023
PRIMARY RxNorm
NCI_THESAURUS
C72124
Created by admin on Fri Dec 15 15:19:50 GMT 2023 , Edited by admin on Fri Dec 15 15:19:50 GMT 2023
PRIMARY
WIKIPEDIA
Propyphenazone
Created by admin on Fri Dec 15 15:19:50 GMT 2023 , Edited by admin on Fri Dec 15 15:19:50 GMT 2023
PRIMARY
ChEMBL
CHEMBL28318
Created by admin on Fri Dec 15 15:19:50 GMT 2023 , Edited by admin on Fri Dec 15 15:19:50 GMT 2023
PRIMARY
CAS
479-92-5
Created by admin on Fri Dec 15 15:19:50 GMT 2023 , Edited by admin on Fri Dec 15 15:19:50 GMT 2023
PRIMARY
PUBCHEM
3778
Created by admin on Fri Dec 15 15:19:50 GMT 2023 , Edited by admin on Fri Dec 15 15:19:50 GMT 2023
PRIMARY
MESH
C009077
Created by admin on Fri Dec 15 15:19:50 GMT 2023 , Edited by admin on Fri Dec 15 15:19:50 GMT 2023
PRIMARY
EPA CompTox
DTXSID6023529
Created by admin on Fri Dec 15 15:19:50 GMT 2023 , Edited by admin on Fri Dec 15 15:19:50 GMT 2023
PRIMARY
CHEBI
135538
Created by admin on Fri Dec 15 15:19:50 GMT 2023 , Edited by admin on Fri Dec 15 15:19:50 GMT 2023
PRIMARY
DAILYMED
OED8FV75PY
Created by admin on Fri Dec 15 15:19:50 GMT 2023 , Edited by admin on Fri Dec 15 15:19:50 GMT 2023
PRIMARY
DRUG BANK
DB13524
Created by admin on Fri Dec 15 15:19:50 GMT 2023 , Edited by admin on Fri Dec 15 15:19:50 GMT 2023
PRIMARY